הלוואות ואשראי לטווח ארוך של החברה Amphastar (AMPH)

The current market quotes for Amphastar Pharmaceuticals (AMPH) visualized below on GURU.Markets rely on the human capital of Amphastar Pharmaceuticals (AMPH), where technologists develop rare dosage forms and the indicator stands at 0.65. The business generates profit through pricing power over critical drugs with low demand elasticity, while the company strictly adheres to medical regulations regarding waste processing and the energy efficiency of its production sites.

This indicator aggregates all credit obligations with a maturity of more than one year, capturing the dynamics of borrowed capital and its impact on financial stability. Analyzing the magnitude of long-term liabilities for Amphastar Pharmaceuticals (AMPH) allows for an assessment of the cost of scaling the production of inhalation drugs and generics, where a sharp upward trend may signal an increasing debt burden on operating profit.